Cancer surveillance worldwide: before, during and after the COVID-19 pandemic
Professor of Global Public Health, Claudia Allemani will deliver her inaugural lecture and discuss her career and research in care and survival for cancer patients.
In this inaugural lecture, Claudia Allemani, Professor of Global Public Health, will portray her 20-year career trajectory in monitoring international trends and inequalities in patterns of care and survival for cancer patients, to help shape strategies for cancer control. She will discuss past, present and future difficulties in leading global research programmes in public health surveillance.
Speaker
Claudia Allemani, LSHTM
Claudia Allemani is Professor of Global Public Health at the London School of Hygiene and Tropical Medicine. Her background covers the range from applied mathematics to public health and education, via epidemiology and medical statistics. She graduated [laurea magistrale] in mathematics from the University of Turin, Italy, in 1996, followed by a Master’s degree in Statistical and Informatic Methods for data analysis in the University of Milan, Italy, in 1998, then a specializzazione [PhD equivalent] in Medical Statistics in 2001 and a PhD in Public Health and Education in 2006, both in the University of Pavia, Italy. She was elected a Fellow of the UK Higher Education Academy in 2012, and an Honorary Member of the UK Faculty of Public Health in 2014. She was awarded the Faculty’s inaugural Global Public Health Award in 2016. In 2021, she joined The Lancet Oncology International Advisory Board and the WHO Global Breast Cancer Initiative Working Group.
Her main interests are in international comparisons of cancer survival trends (EUROCARE, HAEMACARE, CONCORD), “high‐resolution” studies on patterns of care, and the estimation of avoidable premature deaths, all with a focus on their impact on cancer policy. She has over 20 years’ experience in this domain. She leads the data management, quality control and survival analyses for the global surveillance of cancer survival (CONCORD), for which she is co‐Principal Investigator. In 2017, she obtained a prestigious European Research Council Consolidator grant to carry out a world‐wide study on inequalities in survival from cancers of the breast, cervix and ovary (VENUSCANCER).
She collaborates with the Organisation for Economic Co-operation and Development (OECD) and with several other international agencies, including the International Atomic Energy Agency (IAEA), the World Health Organisation, the US Centers for Disease Control and Prevention (CDC), the American Cancer Society (ACS) and the French National Cancer Institute (INCa), as well as the European Cancer Patient Coalition (ECPC).
Please note, the lecture will take place in the Manson Lecture Theatre from 17.15 - 18.15 followed by a drinks reception from 18.15 - 19.15 in the South Courtyard.
Admission
Contact
